Stryker Corporation SYKis one of the underperforming companies in the MedTech space. In the past month, the shares of the company have lost 7.6%, compared with the industry’s decline of 7.1%. Challenging global economic conditions, supply side issues, fluctuations in foreign currency exchange rates, and a strengthening U.
S. dollar pose major headwinds to Stryker’s top-line growth.Stryker Loses 7.6% in a Month: What's Weighing It Down?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться